American Century Companies
SGNT

American Century Companies’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

American Century Companies’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-26,124
Closed -$400K – 1448
2015
Q3 		$400K Sell
26,124
-168,384
-87% -$3.64M ﹤0.01% 1250
2015
Q2 		$4.73M Buy
194,508
+19,315
+11% +$463K 0.01% 858
2015
Q1 		$4.07M Buy
175,193
+72,524
+71% +$1.92M ﹤0.01% 904
2014
Q4 		$2.58M Buy
+102,669
New +$3.01M ﹤0.01% 1026

Other funds holding SGNT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Century Companies's SGNT Position: Q4 2015 in Review

American Century Companies sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q4 2015, closing a stake of 26,124 shares — an estimated $400K sold.

American Century Companies first reported a position in SGNT in Q4 2014 and held it in 4 quarters. The position peaked at $4.73M in Q2 2015. 134 funds tracked by Wall St. Rank hold SGNT as of Q4 2015.

  • American Century Companies reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
  • American Century Companies sold 26,124 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q4 2015, an estimated $400K.
  • American Century Companies first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2014 and held it in 4 quarters.
  • American Century Companies's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $4.73M in Q2 2015.
  • 134 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q4 2015.

Based on American Century Companies's 13F filing for Q4 2015, filed 1 Feb 2016.